SCHEMBL19239359

SCHEMBL19239359

c1ccc(-c2nc(-c3cccc4oc5ccccc5c34)nc(-n3c4ccccc4c4cc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)ccc43)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PTGER4 P35408 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.32
LMNA P02545 1/20 0.32
PLA2G2A P14555 2/20 0.32
PLA2G4A P47712 2/20 0.32
PLA2G10 O15496 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.31
SIRT2 Q8IXJ6 1/20 0.31
SIRT1 Q96EB6 1/20 0.31
BACE1 P56817 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
ALDH1A1 P00352 2/20 0.30
TSHR P16473 2/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19239369 0.99 KDM4E (0.36) KDM4EATML3MBTL1PTGER4SMN1; SMN2
SCHEMBL19239351 0.99 KDM4E (0.36) KDM4EATML3MBTL1PTGER4SMN1; SMN2
SCHEMBL19239360 0.97 KDM4E (0.35) KDM4EATML3MBTL1PTGER4SMN1; SMN2
SCHEMBL19239361 0.97 KDM4E (0.35) KDM4EATML3MBTL1PTGER4SMN1; SMN2
SCHEMBL26287293 0.97 KDM4E (0.36) KDM4EATML3MBTL1PTGER4SMN1; SMN2
SCHEMBL19239368 0.97 KDM4E (0.39) KDM4EATML3MBTL1PTGER4SMN1; SMN2
SCHEMBL22267441 0.96 KDM4E (0.34) KDM4EATML3MBTL1PTGER4SMN1; SMN2
SCHEMBL20821854 0.96 KDM4E (0.34) KDM4EATML3MBTL1PTGER4SMN1; SMN2
SCHEMBL26287291 0.96 KDM4E (0.35) KDM4EATML3MBTL1PTGER4SMN1; SMN2
SCHEMBL24701655 0.96 KDM4E (0.38) KDM4EATML3MBTL1PTGER4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9876181-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2018-01-23 US disclosed
US-9876181-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2018-01-23 US disclosed
US-20170237017-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2017-08-17 US disclosed
US-20170237017-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170237017-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES DDT, ETFA, TST KDM4E 1629/4885ATM 4129/4885L3MBTL1 1145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.